Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGER3 | P43115 | 19/20 | 0.55 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.53 |
| ▸ | MEN1 | O00255 | 3/20 | 0.53 |
| ▸ | MAPT | P10636 | 3/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.53 |
| ▸ | RAB9A | P51151 | 1/20 | 0.53 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.48 |
| ▸ | RECQL | P46063 | 1/20 | 0.48 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.46 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL688515 | 0.90 | PTGER3 (0.55) | PTGER3KDM4EMEN1KMT2AALDH1A1 | |
| SCHEMBL687857 | 0.89 | PTGER3 (0.55) | PTGER3KDM4EMEN1KMT2AALDH1A1 | |
| SCHEMBL687769 | 0.88 | PTGER3 (0.62) | PTGER3KDM4EMEN1MAPTKMT2A | |
| SCHEMBL687891 | 0.87 | PTGER3 (0.69) | PTGER3KDM4EMEN1MAPTKMT2A | |
| SCHEMBL688035 | 0.86 | CTSA (0.41) | PTGER3KDM4EMEN1MAPTKMT2A | |
| SCHEMBL688548 | 0.86 | MAPT (0.64) | PTGER3KDM4EMEN1MAPTKMT2A | |
| SCHEMBL687926 | 0.85 | PTGER3 (0.55) | PTGER3KDM4EMEN1MAPTKMT2A | |
| SCHEMBL687605 | 0.84 | PTGER3 (0.59) | PTGER3KDM4EMEN1KMT2AALDH1A1 | |
| SCHEMBL687440 | 0.84 | PTGER3 (0.55) | PTGER3KDM4EMEN1MAPTKMT2A | |
| SCHEMBL688009 | 0.83 | PTGER3 (0.58) | PTGER3KDM4EMEN1MAPTKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1203766-B1 | Carboxylic acid derivatives that inhibit the binding of integrins to their receptors | ENCYSIVE PHARMACEUTICALS INC (US) | 2012-02-29 | — | — | EP | disclosed |
| EP-1203766-A2 | Carboxylic acid derivatives that inhibit the binding of integrins to their receptors | TEXAS BIOTECHNOLOGY CORPORATION (US) | 2002-05-08 | — | — | EP | disclosed |